Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Simona Lattanzi; Francesco Brigo; Eugen Trinka; Fabrizio Vernieri; Tommaso Corradetti; Mauro Dobran; Mauro Silvestrini

doi:10.1007/s40265-019-01069-1

Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Simona Lattanzi
, Francesco Brigo
, Eugen Trinka (Co-Autor/-in)
, Fabrizio Vernieri
, Tommaso Corradetti
, Mauro Dobran
, Mauro Silvestrini

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

79 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	417-431
Fachzeitschrift	DRUGS
Jahrgang	79
Ausgabenummer	4
DOIs	https://doi.org/10.1007/s40265-019-01069-1
Publikationsstatus	Veröffentlicht - 2019

Zugriff auf Dokument

10.1007/s40265-019-01069-1

Dieses zitieren

@article{4a9cfbedcc124aa98de55abed805a526,

title = "Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.",

keywords = "EPISODIC MIGRAINE, DOUBLE-BLIND, INTERNATIONAL BURDEN, CGRP RECEPTOR, HEALTH-CARE, COST, PROPHYLAXIS, MEDICATIONS, TOPIRAMATE, ANTAGONIST",

author = "Simona Lattanzi and Francesco Brigo and Eugen Trinka and Fabrizio Vernieri and Tommaso Corradetti and Mauro Dobran and Mauro Silvestrini",

note = "Triinka: Department of Neurology, Christian Doppler KlinikParacelsus Medical UniversitySalzburgAustria",

year = "2019",

doi = "10.1007/s40265-019-01069-1",

language = "English",

volume = "79",

pages = "417--431",

journal = "DRUGS",

issn = "0012-6667",

number = "4",

}

TY - JOUR

T1 - Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.

AU - Lattanzi, Simona

AU - Brigo, Francesco

AU - Trinka, Eugen

AU - Vernieri, Fabrizio

AU - Corradetti, Tommaso

AU - Dobran, Mauro

AU - Silvestrini, Mauro

N1 - Triinka: Department of Neurology, Christian Doppler KlinikParacelsus Medical UniversitySalzburgAustria

PY - 2019

Y1 - 2019

KW - EPISODIC MIGRAINE

KW - DOUBLE-BLIND

KW - INTERNATIONAL BURDEN

KW - CGRP RECEPTOR

KW - HEALTH-CARE

KW - COST

KW - PROPHYLAXIS

KW - MEDICATIONS

KW - TOPIRAMATE

KW - ANTAGONIST

U2 - 10.1007/s40265-019-01069-1

DO - 10.1007/s40265-019-01069-1

M3 - Review article

C2 - 30793254

SN - 0012-6667

VL - 79

SP - 417

EP - 431

JO - DRUGS

JF - DRUGS

IS - 4

ER -